Clinical trials
Withdrawn Phase 2 Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 10 |
| Northwestern University | 3 |
| OHSU Knight Cancer Institute | 3 |
| The University of Texas Health Science Center, Houston | 3 |
| Burzynski Research Institute | 2 |
| Eastern Cooperative Oncology Group | 2 |
| Fox Chase Cancer Center | 2 |
| IRCCS San Raffaele | 2 |
| ImmunityBio, Inc. | 2 |
| University Health Network, Toronto | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 67 |
| Neoplasm Metastasis | 4 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplastic Cells, Circulating | 2 |
| Disease Progression | 1 |
| Endophthalmitis | 1 |
| Esophageal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.